Results 191 to 200 of about 73,750 (253)

Prion diseases disrupt the glutamate/glutamine metabolism in skeletal muscle

, 2023
Caredio D, Koderman M, Frontzek K, Sorce S, Nuvolone M, Bremer J, Schwarz P, Sellitto S, Streichenberger N, Scheckel C, Aguzzi A.   +10 more
europepmc   +1 more source

Updated global epidemiology atlas of human prion diseases. [PDF]

Front Public Health
Gao LP, Tian TT, Xiao K, Chen C, Zhou W, Liang DL, Cao RD, Shi Q, Dong XP.   +8 more
europepmc   +1 more source

Unmet needs of biochemical biomarkers for human prion diseases. [PDF]

Prion
Hermann P, Zerr I.
europepmc   +1 more source

New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry. [PDF]

Vet Q
Pérez-Lázaro S, Barrio T, Bravo SB, Sevilla E, Otero A, Chantada-Vázquez MDP, Martín-Burriel I, Requena JR, Badiola JJ, Bolea R.   +9 more
europepmc   +1 more source

A European initiative on transmissible spongiform encephalopathies (TSE). Communication from the Commission. COM (96) 582 final, 13 November 1996 and COM (96) 582 final/2, 20 December 1996 [PDF]

, 1996

core  

Predicting Symptom Onset of Genetic Prion Diseases Using Fluid Biomarkers. [PDF]

Neurology
Appleby BS.
europepmc   +1 more source

Perspectives on CRISPR Genome Editing to Prevent Prion Diseases in High-Risk Individuals. [PDF]

Biomedicines
Medd MM, Cao Q.
europepmc   +1 more source

Interactions between Cytokines and the Pathogenesis of Prion Diseases: Insights and Implications. [PDF]

Brain Sci
Assis-de-Lemos G, Moura-do-Nascimento R, Amaral-do-Nascimento M, Miceli AC, Vieira TCRG.   +4 more
europepmc   +1 more source

Assessment of the therapeutic potential of Hsp70 activator against prion diseases using in vitro and in vivo models. [PDF]

Front Cell Dev Biol
Zayed M, Kim YC, Jeong BH.
europepmc   +1 more source